Stifel Starts Gemini Therapeutics Inc. (GMTX) at Buy

February 16, 2021 4:43 AM EST
Get Alerts GMTX Hot Sheet
Price: $9.61 +11.48%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 4 | New: 24
Trade Now! 
Join SI Premium – FREE

Stifel analyst Paul Matteis initiates coverage on Gemini Therapeutics Inc. (NASDAQ: GMTX) with a Buy rating and a price target of $20.00.


For an analyst ratings summary and ratings history on Gemini Therapeutics Inc. click here. For more ratings news on Gemini Therapeutics Inc. click here.


Shares of Gemini Therapeutics Inc. closed at $12.56 yesterday.


You May Also Be Interested In





Related Categories

New Coverage